by RxTarget.hu | May 2, 2019 | Publications
The impact of bleeding and comorbidities on the risk of mortality in patients with atrial fibrillation Robert Kiss, Daniel Aradi, Gyorgy Rokszin, Ibolya Fabian, Csaba Andras Dezsi and Bela Merkely (Volume 73, Issue 9 Supplement 1, March 2019, DOI:...
by RxTarget.hu | Apr 25, 2019 | Publications
A 2-es típusú cukorbetegség kardiovaszkuláris megbetegedésre és az összmortalitásra kifejtett korfüggő hatása: országos elemzés a NEAK adatbázisa alapjánKiss Zoltán dr., Rokszin György dr., Abonyi-Tóth Zsolt, Jermendy György dr., Kempler Péter dr., Aradi Dániel dr.,...
by RxTarget.hu | Apr 10, 2019 | Publications
Different Changes of Risks for Stroke and Myocardial Infarction in Patients With Type 2 Diabetes in Hungary Between the Two Periods of 2001–2004 and 2010–2013 Zoltan Kiss, György Rokszin, Zsolt Abonyi-Tóth, György Jermendy, Péter Kempler and István Wittmann (doi:...
by RxTarget.hu | Aug 17, 2018 | Uncategorized
Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study György Jermendy, Zoltán...
by RxTarget.hu | Jul 27, 2018 | Publications
Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary Zoltán Kiss, György Rokszin, Zsolt Abonyi-Tóth, György Jermendy, Péter Kempler, Dániel Aradi and István Wittmann (Cardiovascular...